4-Nitro-2,3-Lutidine-N-Oxide Bulk Price 2026 Global Manufacturer
- Technical Specification: CAS 37699-43-7, Molecular Formula C7H8N2O3, Melting Point 94-98 °C.
- Commercial Application: Critical API intermediate for Lansoprazole synthesis and heterocyclic building blocks.
- Procurement Advantage: Direct global manufacturer supply ensures competitive bulk price and industrial purity standards.
In the landscape of pharmaceutical intermediates, 4-Nitro-2,3-lutidine-N-oxide (CAS 37699-43-7) stands as a pivotal compound for the synthesis of proton pump inhibitors, specifically Lansoprazole. As we approach 2026, the demand for high-quality heterocyclic building blocks continues to surge, driven by the expanding generic pharmaceutical market. Procurement managers and process chemists must navigate significant price disparities between laboratory-scale reagents and industrial bulk supplies. Understanding the technical nuances of this pyridine N-oxide intermediate is essential for securing cost-effective supply chains without compromising on quality.
Comparative Analysis of Lab Scale vs Bulk Pricing Tiers
Market data indicates a steep exponential decay in unit cost as order volume increases from grams to metric tons. Laboratory-grade suppliers often list prices exceeding $200 per 25 grams for research quantities. However, industrial procurement operates on a fundamentally different economic model. When sourcing 2,3-Dimethyl-4-nitropyridine N-Oxide for commercial production, the bulk price is determined by raw material availability, synthesis yield, and purification efficiency.
For process chemists, the cost per kilogram in bulk contracts can be significantly lower than small-scale catalog pricing. This discrepancy arises because bulk manufacturers optimize reaction conditions for throughput rather than convenience. Key factors influencing the 2026 pricing structure include:
- Raw Material Costs: Fluctuations in lutidine and nitration agents.
- Purification Requirements: Achieving >98% purity requires recrystallization or chromatography, impacting final costs.
- Regulatory Compliance: Adherence to REACH and ISO standards adds value but may influence baseline pricing.
Buyers seeking pharmaceutical grade material should expect to pay a premium for comprehensive documentation, including full impurity profiles and stability data, compared to technical grade offerings.
Technical Specifications and Industrial Purity Standards
The chemical integrity of 4-Nitro-2,3-dimethylpyridine N-oxide is critical for downstream synthesis. Impurities can affect the yield of the subsequent reduction steps required to form the aminopyridine core. Industrial standards typically demand a minimum purity of 98.0% (HPLC), with strict limits on related substances.
| Property | Specification |
|---|---|
| CAS Number | 37699-43-7 |
| Molecular Formula | C7H8N2O3 |
| Molecular Weight | 168.15 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Melting Point | 94-98 °C |
| Storage Conditions | Sealed in dry, Room Temperature |
| Solubility | Slightly soluble in Chloroform and Methanol |
Maintaining industrial purity requires rigorous quality control during the oxidation and nitration stages. The presence of residual solvents or isomeric byproducts must be minimized to ensure the material functions effectively as an API intermediate. Reliable suppliers provide Certificates of Analysis (COA) that detail HPLC chromatograms and NMR data to verify structural integrity.
Volume Discounts and Global Shipping Logistics for 2026
As supply chains stabilize post-2025, logistics play a crucial role in the landed cost of chemicals. 4-Nitro-2,3-lutidine-N-oxide is classified under Hazard Class 6.1 (Toxic substances) and Packing Group III for transport. Proper packaging is essential to prevent moisture absorption, which can degrade the N-oxide functionality over time.
Global manufacturers often offer tiered pricing structures based on annual commitment volumes. For example, contracting for multiple metric tons may unlock significant discounts compared to spot purchases. Additionally, Incoterms such as FOB or CIF must be clearly defined to avoid hidden freight costs. In 2026, buyers should anticipate lead times of 2-4 weeks for bulk orders, depending on production scheduling and customs clearance.
Optimizing Synthesis and Supply Chain Efficiency
Efficient production relies on a robust synthesis route that maximizes yield while minimizing waste. When evaluating potential partners, it is vital to assess their capacity for scale-up. A reliable global manufacturer will have dedicated production lines for heterocyclic compounds, ensuring consistency across batches. For detailed insights into optimizing the manufacturing process, buyers should request technical dossiers that outline reaction parameters and safety protocols.
NINGBO INNO PHARMCHEM CO.,LTD. has established itself as a premier source for these specialized intermediates, offering competitive pricing structures tailored to large-scale pharmaceutical production. Their commitment to quality assurance ensures that every batch meets the stringent requirements necessary for GMP environments.
Requesting Custom Quotes from Direct Global Manufacturers
To secure the best value for 4-Nitro-2,3-lutidine-N-oxide, procurement teams should engage directly with manufacturers rather than relying solely on distributors. Direct engagement allows for negotiation on purity specifications, packaging sizes (e.g., 25kg drums vs. 500kg bags), and payment terms.
When requesting a quote, provide the following details to ensure accuracy:
- Target Quantity: Specify initial trial order and projected annual volume.
- Purity Requirements: Define acceptable limits for specific impurities.
- Destination Port: Essential for calculating freight and insurance.
- Documentation Needs: Specify if DMF support or specific COA formats are required.
By leveraging direct relationships with established entities like NINGBO INNO PHARMCHEM CO.,LTD., companies can mitigate supply risks and secure favorable pricing for 2026 and beyond. The market for Lutidine N-oxide derivative compounds is competitive, but quality remains the primary differentiator for successful API synthesis.
Conclusion
The procurement of 4-Nitro-2,3-lutidine-N-oxide requires a balance of technical scrutiny and commercial acumen. While laboratory prices provide a baseline, true cost savings are realized through bulk contracts with verified manufacturers. By focusing on industrial purity, robust logistics, and direct supplier relationships, pharmaceutical companies can ensure a steady supply of this critical intermediate. As the industry moves into 2026, partnering with a capable global manufacturer will be key to maintaining production efficiency and cost competitiveness.